Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1992 Oct;11(10):3501-6.
doi: 10.1002/j.1460-2075.1992.tb05432.x.

Primary and secondary structure of the pore-forming peptide of pathogenic Entamoeba histolytica

Affiliations
Comparative Study

Primary and secondary structure of the pore-forming peptide of pathogenic Entamoeba histolytica

M Leippe et al. EMBO J. 1992 Oct.

Abstract

A pore-forming peptide is implicated in the potent cytolytic activity of pathogenic Entamoeba histolytica. Using NH2-terminal sequence information of this peptide, the corresponding cDNA was isolated. The cDNA-deduced amino acid sequence revealed a putative signal peptide and a mature peptide of 77 amino acids including six cysteine residues. Computer-aided secondary structure analysis predicted that the peptide would be composed of four adjacent alpha-helices, and CD spectroscopy indicated an all alpha-helical conformation. The tertiary structure appears to be stabilized by three disulfide bonds; the pore-forming activity was not sensitive to heat but was lost in the presence of reducing agents. Sequence homology was found to the saposins and to surfactant-associated protein B, both mammalian polypeptides of similar size and secondary structure but of non-lytic function. In particular, the six cysteine residues were found to be conserved, suggesting a common motif for stabilizing a favourable tertiary structure. Compared with previously characterized toxic peptides also containing three disulfide bonds, the amoeba peptide may represent a distinct class of biologically active peptides.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Experientia. 1990 Feb 15;46(2):180-92 - PubMed
    1. Mol Microbiol. 1991 Sep;5(9):2153-64 - PubMed
    1. FASEB J. 1991 Mar 1;5(3):301-8 - PubMed
    1. Proteins. 1990;8(2):103-17 - PubMed
    1. Mol Immunol. 1990 Jul;27(7):589-602 - PubMed

Publication types

MeSH terms